In vivo Nanoplatforms (IVN)
Abstract
The In vivo Nanoplatforms (IVN) program seeks to develop the nanoscale systems necessary for in vivo sensing and physiologic monitoring and delivery vehicles for targeted biological therapeutics. The nanoscale components to be developed will enable continuous in vivo monitoring of both small (e.g. glucose, lactate, and urea) and large molecules (e.g. biological threat agents). A reprogrammable therapeutic platform will enable tailored therapeutic delivery to specific areas of the body (e.g. cells, tissue, compartments) in response to traditional, emergent, and engineered threats. The key challenges to developing these systems include safety, toxicity, biocompatibility, sensitivity, response, and targeted delivery. The IVN program will have diagnostic and therapeutic goals that enable a versatile, rapidly adaptable system to provide operational support to the warfighter in any location.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2014
- Source ID
- c574777a05692e9c764fe0cb721681d1
Related Documents
- Root: ELECTRONICS TECHNOLOGY